Table 1 Sociodemographic data of the study groups including stage, therapies, participation rate

CG

BC

CRC

CG

BC

CRC

Died

2

14

25

Invited (n):

131

95

51

117

81

26

Consented (n):

120

95

51

85

62

17

Complete Data (n):

115

95

49

Censored Data

7

4

1

Women (n):

80

95

30

Age (mean):

54

57.1

62

(SD)

(14.2)

(9.9)

(12.2)

Marital Status:

Married (n/%)

75/65.2

59/62.1

33/67.3

Single (n/%)

13/11.3

8/8.4

6/12.2

Divorced (n/%)

15/13.0

13/13.7

5/10.2

Widowed (n/%)

8/7.0

9/9.5

4/8.2

No details available (n/%)

4/3.4

6/6.3

1/2.0

Most recent profession:

Worker (n/%)

6/5.2

12/12.6

12/24.4

Employee/civil servant (n/%)

72/62.6

45/47.4

22/44.9

Self employed (n/%)

19/16.5

8/8.4

5/10.2

House wife/husband (n/%)

12/10.4

23/24.2

10/20.4

Still in education (n/%)

3/2.6

0/0

0/0

No details available (n/%)

3/2.6

7/7.3

0/0

Pension (n/%)

Karnofsky-I.

%(SD) of survivors:

96.7(7.2)

88.2(12.5)

UICC stages (n/%):

I

28/29.5

6/12

II

37/38.9

9/18

I/II

3/3.2

-

III

4/4.2

15/29

II/III

-

2/4

IV

23/24.2

19/37

Grading (SD):

2.0(0.62)

2.25(0.51)

Metastasis localisation (n/%):

Bone

5/5.2

1/1.9

Liver

-

8/15.7

Peritoneal

-

2/3.9

Lung

2/2.1

-

Multiple

9/9.4

7/13.7

others

5/5.2

1/1.9

Duration of disease

(Mean/SD):

4.7/5.6

1.7/2.3

Menopausal status at diagnosis:

Premenopausal (n/%)

38/39.6

Postmenopausal (n/%)

53/55.2

Treatment:

Operation: n/%

93/97.9

51/100

Chemotherapy: n/%

55/57.9

22/44

Radiotherapy: n/%

55/57.9

8/15.7

antihormonal therapy.: n/%

55/57.9

-

mistletoe therapy: n/%

79/83.2

38/71.7